None listed
Conditions
Interventions
None listed
Sponsors
Korea University Ansan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: · Patients diagnosed with type 2 diabetes (regardless of treatment method) · Patients who have undergone CGM more than once within the past year from the date of commencement of the study or all patients who undergo CGM from the date of commencement of the study - Among the patients who previously agreed to link their CGM data to the lab-connect system, those who wish to participate in this study
Exclusion criteria
Exclusion criteria: · a type 1 diabetic · If you take drugs that may affect your current blood sugar, such as systemic steroids and obesity treatment drugs · Patients whose clinical studies are deemed inappropriate (pregnant, severe systemic disease, mental illness, etc.) · A malignant tumor is diagnosed within one year from the date of enrollment in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Continuous Glucose Monitoring Patterns and Inbody Data | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences between groups in the rates of hypoglycemia and severe hypoglycemia;Differences between groups in the incidence of allergic reactions | — |
Countries
Korea, Republic of
Contacts
Public ContactSeungA Park
Korea University Ansan Hospital
Outcome results
None listed